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PAINFUL DIABETIC POLYNEUROPATHY (DPN)
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Summary
Diabetic polyneuropathy represents mostly symmetrical damage of the peripheral 
nerves associated with diabetes mellitus.
Clinical picture depends on the duration of diabetes, glucose blood level and insulin 
use.
Distal symmetric polyneuropathy is the most common neuropathy of diabetes. It 
presents with sensory symptoms, paresthesiae and fingers pain in the hands and legs. 
Isolated forms of DPN are asymmetrical (focal or multifocal) and autoimmune form.
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Prevalence
Peripheral neuropathies represent the most common acquired disorders of 
the nervous system, and the diabetic neuropathy is the most represented. The 
rising global prevalence of type 2 diabetes mellitus will lead to a further rise in 
polyneuropathy, known to involve approximately 65% of all patients with diabe-
tes. Of this 16% suffers from painful diabetic polyneuropathy.
Diagnostic criteria 
The diagnosis of DPN requires history taking and neurological examina-
tion. It must be concluded if patient suffers from diabetes or impaired glucose 
tolerance, and if other end-organ complications of diabetes, such as retinopathy 
or nephropathy persist. According to history of the patient it has to be learned if 
the onset is gradual and chronic, since subacute onset may suggest alternative 
cause. Moreover, it has to be found if sensory symptoms and findings are promi-
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nent (motor symptoms suggest alternative cause). Helpful information would be 
if skin ulcerations, retinal abnormalities and sings of possible autonomic symp-
toms or signs persist. 
In algorithm glycemia records, hemoglobin and microalbuminuria has to be 
evaluated. In order to exclude other causes of polyneuropathy thyroid-stimulating 
hormone, B12, HIV serology must be preformed. Ancillary tests include autonomic 
testing and corneal confocal microscopy. Corneal confocal microscopy represents 
a novel noninvasive approach toward the early diagnosis of axonal damage. 
Also, lumbar MRI should be performed if spinal stenosis is suspected.
The most important examination is electromyography of upper and lower 
limbs. It is gold standard in diabetic polyneuropathy. Electrophysiology is used 
to exclude carpal tunnel syndrome and ulnar neuropathy, plexopathies and ot-
her polyneuropathies. 
Electromyography with a needle electrode is used to determine innervation 
sample, form of active potential and the presence of positive waves and fibrilla-
tions.
Motor nerve conduction testing is obligatory to perform in, at least 3 nerves, 
and to analyze distal latency, amplitude and evoked potential as well as analyze 
of sensory action potentials. Electromyography analyzes only the thicker myeli-
nated fibers which constitute 25% of the peripheral nerve. Early detection of di-
abetic polyneuropathy is important for early treatment and delay of irreversible 
changes of peripheral nerves.
Painful diabetic polyneuropathy is very unpleasant sensory and emotional 
experience. Problems are greater when patient rests, they can be easily provoked 
and they usually appear during the night 
Diabetic polyneuropathy disturbs the dream, reduces working energy and 
impairs quality of life. Chronic pain leads to depression. Therefore, special atten-
tion is required in treatment of painful symptoms.
new MechanisMs
Pathogenesis of painful diabetic polyneuropathy is not clearly understood.
The polyol hypothesis has generated trials of aldose reductase inhibitors but 
with mixed results. Well described mechanisms include microangiopathy and 
hypoxia involving the peripheral nerve trunk, ganglia or spinal cord, oxidative 
and nitratitive stress from free radicals, deficiency of growth factors or their up-
take and abnormal glycolisation of structural neuron proteins. 
The impact of alpha-lipoic acid, an antioxidant compound, has been analy-
zed in several trials with significant improvement of neuropathy.
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The possible role of insulin in the pathogenesis of diabetic polyneuropat-
hy has had less attention. The local administration of insulin achieved poor re-
sults. A novel prospect is the possibility of administering insulin intranasally an 
approach that can access the cerebrospinal fluid and has been used to treat other 
neurological conditions.
Intrathecal administration in rat experimental model indicated the trophic 
support of insulin on peripheral neurons.
C peptide, a cleaved portion of the insulin prohormone, is postulated to have 
independent actions on peripheral neurons. It was demonstrated in early clini-
cal trials.  
Interruption of advanced glycation endproducts - receptor for advanced gl-
ycation endproducts (AGE-RAGE) signaling is a novel examined strategy. Expe-
rimental studies using mice model showed that interruption of AGE-RAGE si-
gnaling would protect neurons from neuropathy.
treatMent
The treatment is based on tight glycemia regulation, physical therapy, 
kinesitherapy and symptomatic medical therapy. 
According to the guidelines of European Neurological Society and also Cro-
atian Neurological Society the treatment with antidepressants, antiepileptic 
drugs and opioids is recommended. Antidepressants and antiepileptic drugs 
have specific action on ion channels.
Antidepressants used in treatment include tricyclic antidepressants (TCAs) 
and selective serotonin norepinephrine reuptake inhibitors (SSNRIs). They act 
through mechanisms involving block of sodium channels.
Recommended antiepileptic drugs are: pregabalin and gabapentin. They act 
through calcium channels in afferent fibers and reduce release of neurotransmi-
tters.
Opioids are used in acute phase of painful syndrome. However, the chronic 
use is controversial due to possibilities of creating habits. They inhibit pain in 
presynaptic and postsynaptic receptors in the dorsal horn. 
Recommendations for treatment are as follows:
First-line treatment is treatment with antiepileptic drugs: gabapentin (1200-
3600 mg/day), and pregabalin (150-600 mg/day) and antidepressants from SNRI 
group: duloxetin (60-120 mg/day) and TCA: amitriptyline (10-60 mg/day). Second 
or third line represents treatment with lamotrigine (200-400 mg/day), SNRI and 
opioids: Tramadol (250-400 mg/day).
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In conclusion, treatment of diabetic polineuropathy today is based upon spe-
cific and selective blocking of ion channels. New approach toward the treatment 
of diabetic polyneuropathy involves AGE-RAGE pathway direct insulin signa-
ling of neurons.
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Sažetak
Bolna dijabetička polineuropatija
Dijabetička polineuropatija kao jedna od komplikacija dijabetesa melitusa klinički se mani-
festra kao simetrično oštećenje strukture i funkcije perifernih živaca. Stupanj oštećenja i klinička 
slika ovise o trajanju dijabetesa, terapiji koju bolesnici uzimaju te vrijednostima glukoze u krvi. 
Distalna simterična polineuropatija kao najčešća komplikacija dijabetesa klinički se prezentira 
senzornim simptomima, parestezijama i bolovima u prstima ruku i nogu. Izolirane forme disalne 
dijabetičke polineuropatije mogu biti i asimterične (fokalne i multifokalne) i autoimune forme. 
Ključne riječi: dijabetička polineuropatija; liječenje.
